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Abstract
Background: Excessive accumulation of body fat, in particular in the visceral fat depot, is a major risk factor to
develop a variety of diseases such as type 2 diabetes. The mechanisms underlying the increased risk of obese
individuals to develop co-morbid diseases are largely unclear.
We aimed to identify genes expressed in subcutaneous adipose tissue (SAT) and visceral adipose tissue (VAT) that
are related to blood parameters involved in obesity co-morbidity, such as plasma lipid and glucose levels, and to
compare gene expression between the fat depots.
Methods: Whole-transcriptome SAT and VAT gene expression levels were determined in 75 individuals with a BMI
>35 kg/m
2. Modules of co-expressed genes likely to be functionally related were identified and correlated with
BMI, plasma levels of glucose, insulin, HbA1c, triglycerides, non-esterified fatty acids, ALAT, ASAT, C-reactive protein,
and LDL- and HDL cholesterol.
Results: Of the approximately 70 modules identified in SAT and VAT, three SAT modules were inversely associated
with plasma HDL-cholesterol levels, and a fourth module was inversely associated with both plasma glucose and
plasma triglyceride levels (p < 5.33 × 10
-5). These modules were markedly enriched in immune and metabolic
genes. In VAT, one module was associated with both BMI and insulin, and another with plasma glucose (p < 4.64
×1 0
-5). This module was also enriched in inflammatory genes and showed a marked overlap in gene content with
the SAT modules related to HDL. Several genes differentially expressed in SAT and VAT were identified.
Conclusions: In obese subjects, groups of co-expressed genes were identified that correlated with lipid and
glucose metabolism parameters; they were enriched with immune genes. A number of genes were identified of
which the expression in SAT correlated with plasma HDL cholesterol, while their expression in VAT correlated with
plasma glucose. This underlines both the singular importance of these genes for lipid and glucose metabolism and
the specific roles of these two fat depots in this respect.
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It has been proposed that obesity-induced chronic
inflammation in adipose tissue precedes the develop-
ment of insulin resistance and type 2 diabetes. Many
inflammatory mediators have been found to be present
at increased levels in obese subjects, including Tumor
Necrosis Factor (TNF), C-reactive protein (CRP), inter-
leukin-6 (IL-6), and the neutrophil products myeloper-
oxidase and calprotectin [1-4]. It was also shown that
chronic inflammation in obesity is associated with the
influx of macrophages into visceral adipose tissue
[5-8]. Visceral adipose tissue (VAT) appears to have a
larger effect on metabolism than subcutaneous fat
(SAT). For example, individuals with a larger visceral
fat mass show increased triglyceride levels and an
increased risk of developing obesity co-morbidities
such as type 2 diabetes and atherosclerosis. Evidence
for this has been found by epidemiological studies
relating waist-to-hip ratio or waist circumference with
obesity-related co-morbidity [1,9,10]. However, the bio-
logical processes that underlie this differential impact
of the two fat depots on metabolic disease are still
obscure.
Although genome-wide association studies have
identified many obesity and type 2 diabetes suscept-
ibility genes, most of the individual differences in dis-
ease susceptibility among obese subjects are still
unclear. A second hypothesis-free and potentially
powerful approach to investigate biological processes
in obese individuals is genome-wide expression profil-
ing. The potential of this method is underscored by
recent studies that have identified numerous genes
differentially expressed after weight loss [11-13].
These genes are candidates to play a role in obesity-
related co-morbidities, since weight loss improves the
metabolic and inflammatory parameters associated
with obesity co-morbidities [14,15]. However, to our
knowledge, no studies have reported direct investiga-
tion of relationships between obesity-related meta-
bolic traits and genome-wide expression levels in
both subcutaneous and visceral adipose tissue within
obese individuals.
We determined genome-wide transcription levels in
both subcutaneous adipose tissue and visceral adipose
tissue obtained from a large group of severely obese
patients some of whom had type 2 diabetes and/or non-
alcoholic steatohepatitis (NASH). From these data we
extracted groups of highly co-expressed genes. Subse-
quent correlation of these genes with metabolic para-
meters such as plasma glucose, insulin, cholesterol,
triglycerides, and non-esterified free fatty acids revealed
genes expressed in adipose tissue that are related to
these parameters.
Methods
Study population
From April 2006 to January 2009, we recruited 75
severely obese subjects with a BMI between 35 and 70
who underwent elective bariatric surgery at the Depart-
ment of General Surgery, Maastricht University Medical
Centre (Maastricht, the Netherlands). Patients with
acute or chronic inflammatory diseases (e.g. auto-
immune diseases), degenerative diseases, reported
alcohol consumption (>10 g/day), or who used anti-
inflammatory drugs were excluded. This study was
approved by the Medical Ethics Board of Maastricht
University Medical Centre, in line with the ethical
guidelines of the 1975 Declaration of Helsinki. Informed
consent was obtained in writing from each individual.
Tissue sampling and RNA isolation
Venous blood samples were obtained after 8 hours fasting
on the morning of surgery. All blood samples were col-
lected in pre-chilled tubes and processed for analysis of
various metabolic traits (shown in table 1) by routine clini-
cal chemistry. Wedge biopsies of visceral adipose tissue
(omentum majus), and subcutaneous adipose tissue
(abdominal) were taken during surgery. Type 2 diabetes
was defined according to the WHO criteria and NASH
was diagnosed according to Brunt’s criteria [16]. RNA was
isolated using the Qiagen Lipid Tissue Mini Kit (Qiagen,
Hilden, Germany, 74804) and RNA quality and concentra-
tion was assessed with an Agilent Bioanalyzer (Agilent
Technologies, Waldbronn, Germany, 5067-1521).
RNA pre-hybridization processing and hybridization
Starting with 200 ng of RNA, the Ambion Illumina
TotalPrep Amplification Kit was used for anti-sense
RNA synthesis, amplification, and purification, according
to the manufacturer’s protocol (Applied Biosystems/
Ambion, Austin, TX, USA). 750 ng of complementary
RNA was hybridized to Illumina HumanHT12 Bead-
Chips (Illumina, San Diego, CA, USA) and scanned on
the Illumina BeadArray Reader. These micro arrays con-
tain 48,813 different probes targeting 37,812 different
genes; some genes are targeted by more than one probe.
Data normalization and quality control
Data were quantile-quantile normalized per tissue using
Genespring GX software (Agilent technologies). Only
samples were included that passed quality control filter-
ing, which was based on the median probe intensity, the
correlation with all other samples for the same tissue,
general behaviour of known housekeeping genes, and
principal component analysis over the samples. All
expression data has been made freely available by sub-
mission to GEO under GSE22070.
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To find direct associations between gene expression
levels and patient characteristics, Spearman rank corre-
lation coefficients were determined between all available
quantile-quantile normalized probe expression values
and values of the measured traits. To identify differen-
tially expressed genes in SAT and VAT a Wilcoxon
Mann-Whitney U-test was used (as implemented in
Genespring GX, Agilent technologies).
Next, for SAT and VAT separately, modules of highly
co-expressed genes were constructed using pair wise
average-linkage cluster analysis as described earlier [17].
First, Pearson correlation coefficients were determined
between all the probes on the microarray. Probes with
low expression values were not excluded because it is
hard to determine a justified cut-off for exclusion of
such probes. In addition, noise signals can be considered
to be random and are thus not expected to show any
co-expression across patients. We used Pearson correla-
tion coefficients because we applied quantile-quantile
normalization to the data and using these coefficients is
a generally accepted method to construct co-expression
networks. We did not take into account negative corre-
lations between probes because this could lead to clus-
tering of genes that are involved in mutually exclusive
processes. After determination of correlation correla-
tions between all possible probe pairs, the strongest cor-
related probe-pair was selected, and grouped together in
a module that was assigned the average expression value
of the two probes that constitute this module. After
addition of this newly created module to the dataset, the
two individual probes were removed from the data and
the strongest correlation (either between probe-pairs,
module-pairs or probe-module-pairs) in the dataset was
again selected. This resulted in either the expansion of a
module already created (when the strongest correlation
Table 1 Clinical and plasma parameters of the study population
All individuals Individuals without
type 2 diabetes and
NASH
Type 2 diabetes
patients
NASH patients Individuals with type 2
diabetes and NASH
No. of
individuals/
Mean (SD)
Minimal/
maximal
values
No. of
individuals/
Mean (SD)
Minimal/
maximal
values
No. of
individuals/
Mean (SD)
Minimal/
maximal
values
No. of
individuals/
Mean (SD)
Minimal/
maximal
values
No. of
individuals/
Mean (SD)
Minimal/
maximal
values
Number of
individuals
75 29 25 41 20
Male/
female
22/53 7/22 7/18 12/29 4/16
Age (years) 44.4 (9.9) 17 - 67 40.3 (9.2) 17 - 54 48.2 (9.4) 28 - 67 45.8 (8.9) 28 - 65 46.5 (8.1) 28 - 65
BMI (kg/m
2) 46.5 (9.6) 34.6 - 73.6 42.6 (6.5) 34.6 - 56.8 49.4 (11.4) 34.8 - 73.6 48.7 (10.8) 34.8 - 73.6 49.6 (12.1) 34.8 - 73.6
Glucose
(mmol/l)
6.60 (2.1) 4.3 - 14.5 5.53 (0.49) 4.3 - 6.5 8.73 (2.5) 4.3 - 14.5 7.16 (2.56) 4.3 - 14.5 8.8 (2.72) 4.3 - 14.5
Insulin
(mU/l)
19.3 (10.9) 3.8 - 53 16.7 (8.8) 5.6 - 37 20.6 (13.1) 5.5 - 53 20.9 (11.1) 3.8 - 49 20.4 (10.9) 3.8 - 49
HbA1c 6.58 (1.39) 5.1 - 12.1 6 (0.54) 5.1 - 7.2 7.9 (1.78) 5.3 - 12.1 6.88 (1.65) 5.2 - 12.1 7.85 (1.88) 5.2 - 12.1
Total
cholesterol
(mmol/l)
5.08 (1.1) 3 - 9.8 4.93 (0.65) 3.5 - 6.1 5.15 (1.43) 3.5 - 9.8 5.08 (1.23) 3 - 9.8 5.2 (1.5) 3 - 9.8
HDL
cholesterol
(mmol/l)
0.98 (0.38) 0.5 - 2.8 1.05 (0.3) 0.6 - 1.9 0.8 (0.23) 0.5 - 1.3 0.93 (0.44) 0.5 - 2.8 0.78 (0.22) 0.5 - 2.8
LDL
cholesterol
(mmol/l)
3.22 (1.02) 1.1 - 7.4 3.16 (0.86) 1.1 - 4.3 3.29 (1.18) 1.5 - 7.4 3.17 (1.06) 1.5 - 7.4 3.32 (1.25) 1.5 - 7.4
TG (mmol/l) 2.26 (2.12) 0.63 - 16.4 1.67 (0.95) 0.63 - 4.2 3.31 (3.46) 0.88 - 16.4 2.73 (2.71) 0.88 - 16.4 3.56 (3.67) 0.88 - 16.4
NEFA
(mmol/l)
0.64 (0.32) 0.12 - 1.66 0.52 (0.34) 0.12 - 1.66 0.72 (0.3) 0.16 - 1.33 0.71 (0.28) 0.21 - 1.33 0.76 (0.29) 0.21 - 1.33
ALAT (U/l) 25.7 (16.5) 6 - 124 19.8 (6.3) 7 - 37 32.3 (23.1) 10 - 124 27.7 (19.3) 6 - 124 32.4 (24.8) 6 - 124
ASAT (U/l) 25.3 (12.9) 7 - 72 21.1 (11.6) 7 - 50 28.9 (15.4) 8 - 72 28.4 (13) 8 - 72 30.7 (16) 8 - 72
CRP (mg/l) 10.2 (8.5) 1 - 37 9.9 (9.2) 1 - 37 13.1 (10) 1.7 - 35 10 (8.2) 1.7 - 35 12.8 (10.2) 1.7 - 35
Data are means ± standard deviation (SD) and the minimal and maximal values for each trait. Data are given for all individuals, individuals without type2
diabetes or NASH, type 2 diabetes patients, NASH patients, and individuals with both type 2 diabetes and NASH. Patients with type 2 diabetes are 36, 37, 40, 42,
43, 49, 51, 54, 55, 57, 60, 63, 64, 65, 69, 75, 77, 78, 79, 85, 87, 97, 101, 103, and 110 - IDs are concordant with the IDs used submitted to the Gene Expression
Omnibus database. Patients with NASH are 38, 42, 43, 44, 45, 47, 49, 51, 52, 53, 54, 57, 58, 60, 62, 63, 64, 65, 69, 72, 75, 78, 79, 83, 85, 87, 88, 92, 93, 95, 97,9 9 ,
100, 101, 102, 103, 104, 105, 107, 110, and 113. TG, triglycerides; NEFA, non-esterified fatty acid; ALAT, alanine aminotransaminase; ASAT, aspartate
aminotransaminase; CRP, C-reactive protein; NASH, non-alcoholic steatohepatitis.
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Page 3 of 15was between a probe and a module or between two
modules) or in the creation of a new module (when the
strongest correlation was between two probe-pairs). We
kept repeating this as an iterative process until the most
significantly correlated pair was r < 0.65. To visualize
the correlations between probes within the modules we
constructed coloured heatmaps by plotting pair-wise
correlation values of expression of all the probes within
the modules. To calculate significance of overlap in
gene content between modules and between different
datasets we performed Fisher’s exact tests using: http://
research.microsoft.com/en-us/um/redmond/projects/
mscompbio/fisherexacttest.
The module expression - reflecting the average expres-
sion value of the probes constituting that module - was
correlated with metabolic traits using a non-parametric
Spearman rank correlation coefficient, which we chose
because it is the most conservative method. For those
modules that correlated with a trait, additional condi-
tional analyses were performed, taking into account the
possible confounders: menopausal status, hormone treat-
ment and treatment for diabetes, hypertension, dyslipide-
mia, along with all the other traits we measured - thus
gender, age, BMI, plasma levels of glucose, insulin,
HbA1c, triglycerides, non-esterified fatty acids, HDL cho-
lesterol, LDL cholesterol, total cholesterol, CRP, ALAT,
a n dA S A T .T og a i ni n s i g h tw h a tt h e s em o d u l e sr e p r e -
sent, the Panther classification system [18,19] was used
to find over- or underrepresented biological themes in
the different modules. To visualize the relevant modules,
graphs were created by connecting those genes within
the modules that were strongly co-expressed (r > 0.65).
Genes residing in modules specific to VAT or SAT or
modules correlated to a metabolic trait were functionally
annotated by manually inspecting KEGG pathways [20],
and Pubmed and OMIM gene descriptions.
Quantitative RT-PCR
In order to estimate the technical quality of the micro
array data we performed a validation experiment using
quantitative RT-PCR (qRT-PCR). By using random stra-
tified selection, as proposed in [21], we picked 10 genes
that were upregulated in SAT, and 10 genes that were
upregulated in VAT (Additional file 1, Table S1). Ran-
dom stratified selection implies that all the genes upre-
gulated in one fat depot were sorted on fold change
values, and divided in 10 bins with an equal amount of
genes. Next, from each bin one gene was randomly
selected (Additional file 1, Table S1). We also measured
expression levels of a gene that showed no difference in
expression between the two fat depots in the micro
array data ("house keeping gene” HKG; Additional file 1,
Table S1). We used the same mRNA as was used for
the micro arrays from 5 individuals. We performed
triplicate measurements and we used a standard curve
to be able to compare absolute transcript quantities. We
calculated the fold change values between SAT and
VAT relative to the HKG and compared these with the
fold changes values we observed in the micro array
experiment. Primers to perform the experiment were
designed using http://www.autoprime.de[22] and
obtained from Biolegio (Nijmegen, The Netherlands).
Primer sequences are shown in Additional file 1, Table
S1. To perform the qRT-PCR we used SYBR green
(Biorad, Veenendaal, The Netherlands) on a 7900HT
Fast Real-Time PCR System (Applied Biosystems, Nieu-
werkerk aan de IJssel, The Netherlands).
Results
Highly variable metabolic disturbances in severely obese
subjects
Among the 75 severely obese subjects studied, 25 were
suffering from type 2 diabetes while 41 were diagnosed
with non-alcoholic steatohepatitis (NASH) (table 1).
Plasma glucose levels varied between 4.3 and 14.5
mmol/l and plasma HDL levels ranged from 0.5 and 2.8
mmol/l. As expected, several of the traits were found to
be highly correlated. (e.g. glucose, triglycerides, and
HbA1C levels) (Additional file 2, Table S2). The degree
of obesity, as reflected by BMI, was correlated to most
of the blood parameters determined, in particular with
HDL and insulin.
Identification of genes overexpressed in subcutaneous
and visceral adipose tissue
We determined genome-wide gene expression profiles of
S A Ta n dV A Tt oi d e n t i f yt h eg e n ee x p r e s s i o nd i f f e r -
ences in adipose tissue that could potentially underlie
the variation described in metabolic traits. After quality
control, 73 SAT samples and 69 VAT samples were
retained for further analysis. RNA Integrity Numbers
(RIN) of these samples ranged between 6.5 and 8.7 in
SAT (average 7.6), and 6.2 and 9.4 in VAT (average
7.5). The qRT-PCR validation experiment showed that
the 20 genes we tested showed very similar fold change
values (correlation coefficient r = 0.88 between the
microarray fold change and qRT-PCR fold change for
the 20 genes) in the qRT-PCR and micro array experi-
ments (Additional file 3, Table S3 and Additional file 4,
Figure S1).
Preliminary analysis of the gene expression profiles
revealed that 1,344 genes were significantly upregulated
(p < 0.05 after Bonferroni correction) in SAT compared
to VAT, with 609 genes showing a >1.5-fold change. In
VAT, we identified 1,246 genes with a significantly
higher expression compared to SAT (p < 0.05 after Bon-
ferroni correction). Of these, 909 showed >1.5-fold
increase (Additional file 5, Table S4A and S4B).
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am o r et h a nt e n - f o l dh i g h e re x p r e s s i o ni nV A Tt h a ni n
SAT, whereas only 20 genes were upregulated by more
than ten-fold in SAT (Additional file 5, Table S4A and
S 4 B ) .S u b s e q u e n tg e n e - s e te n r i c h m e n ta n a l y s i so ft h e
138 genes specifically expressed in VAT using Panther
revealed that they are involved in signal transduction,
cell adhesion, cell communication, and developmental
processes (Bonferroni corrected p < 0.05). The 20 genes
that showed >10-fold higher expression in SAT are
highly enriched in homeobox transcription factors
(HOXA9, HOXA10, HOXC8, HOXC9, IRX2,a n dIRX5).
Additional file 6, Table S5A and S5B, shows the overre-
presented biological processes in the groups of genes
that are differentially expressed in VAT and SAT with
different cut-offs based on fold change (fold change > 1,
fold change > 1.5, and fold change > 10). Some biologi-
cal Panther processes are overrepresented in the lists of
genes with a fold change >1.5 in both VAT and SAT (p
< 0.05 after Bonferroni correction). This might indicate
that these processes - as defined by the Panther classifi-
cation system - are important in both VAT and SAT,
but that these processes are differently moderated in the
distinct fat depots. Panther biological processes that are
overrepresented amongst the genes upregulated >1.5-
fold in both SAT and VAT are “lipid, fatty acid, and
steroid metabolism”, cell structure and motility, develop-
mental processes, cell adhesion, neurogenesis, ectoderm
development, immunity and defense, signal transduc-
tion, cell adhesion-mediated signalling, and cell commu-
nication. Biological processes specifically present in
genes upregulated in SAT are cell structure and vitamin
metabolism. In VAT such specific processes are “recep-
tor protein tyrosine kinase pathway”, cell surface recep-
tor mediated signal transduction, mesoderm
development, ligand-mediated signalling, complement
mediated immunity, muscle contraction, cell prolifera-
tion and differentiation, extracellular matrix protein-
mediated signalling, neuronal activities, cell cycle
control, ion transport, protein modification, protein
phosphorylation, other developmental process, oncogen-
esis, cation transport, and transport.
Gene modules based on co-expression can classify genes
reliably
The expression levels of many individual genes showed
strong correlations with metabolic traits. For example,
as expected BMI and leptin mRNA levels in VAT were
highly correlated (r = 0.51; p = 1.1 × 10
-5). Other exam-
ples included expression levels in subcutaneous fat of
CD68 molecule (CD68) (r= -0.62; p = 2.1 × 10
-8),
CD300a molecule (CD300A) (r= -0.58; p = 2.4 × 10
-7),
and sterol regulatory element binding transcription fac-
tor 1 (SREBF1) (r = 0.53; p = 3.1 × 10
-6), which were
correlated with plasma levels of HDL cholesterol. How-
ever, given the scale of the experiment, it was difficult
to extract meaningful correlations on a gene-by-gene
basis. We therefore chose to apply a clustering method
that enabled us to identify sets of functionally related
genes linked to the phenotypic traits. For this reason,
co-expressed genes were grouped together in “modules”
(figure 1).
In SAT, we identified 67 modules containing 5 or
more genes. These modules comprised 3,263 genes in
total. In VAT, 4,509 genes could be grouped into 76
modules of 5 or more genes (Additional file 7, Table
S6A and S6B). Additional files 8 and 9, Figure S2 and
Figure S3 respectively, show coloured heat-maps of pair-
wise correlations between genes residing in the modules
identified in SAT and VAT. Bright red indicates a
strong negative co-expression, whereas bright green
indicates strong positive co-expression. Expression of
genes within a single module are strongly correlated
whereas genes that belong to different modules generally
do not show strong co-expression. As expected, some
genes residing in different modules are strongly nega-
tively correlated to each other, as module construction
was solely based on gene-pairs, showing strong positive
co-expression.
To confirm that the modules represented coherent
biological processes, an analysis was performed using
the Panther gene classification tool. Importantly, groups
of genes known to be functionally related were indeed
overrepresented in most of the modules (Additional file
10, Tables S7A and S7B), indicating that our modules
reflect consistent biological mechanisms. In addition,
since visceral and subcutaneous adipose tissues are clo-
sely related, we expected to find similar modules in both
tissues. Indeed, most of the modules detected in one of
Figure 1 Bioinformatic data processing showing the steps that
were used to generate modules.
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t h es a m eg e n e si nt h eo t h e ra d i p o s et i s s u e .T h eo v e r l a p
in gene content between modules in VAT and SAT was
confirmed by performing Fisher’s exact tests (table 2).
This again supports the notion that these modules
represent a reliable classification of genes. There was no
module present in SAT with similar contents as module
VAT 4. This module largely consisted of genes that
were higher expressed in VAT than in SAT, and thus
likely represents a process predominantly present in
VAT. Biological processes overrepresented in this mod-
ule are similar to those found in genes strongly higher
expressed in VAT than SAT (Additional file 6, Table
S5B).
Modules of co-expressed adipose tissue genes associated
with specific metabolic traits
Analyses in which we investigated differences in gene
expression between patient groups - i.e. type 2 diabetes
and non-alcoholic steatohepatitis - did not yield statisti-
cally significant results because our dataset has insuffi-
cient power. This is most likely due to complexity of
these phenotypes. Therefore the modules were analyzed
for correlation with various continuous traits of the
obese individuals (figures 2 and 3). In SAT, five modules
were significantly associated with a trait after correcting
for multiple testing (p < 5.33 × 10
-5; Bonferroni cor-
rected p < 0.05) (table 3). Three of these modules (SAT
4, SAT 8, and SAT 39) were inversely correlated to
plasma HDL-cholesterol levels. One module (SAT 13)
showed a correlation to both plasma glucose and plasma
triglyceride levels, and another (SAT 31) was correlated
to gender. In VAT, three modules were significantly cor-
related with a trait (p < 4.64 × 10
-5 ; Bonferroni
corrected p < 0.05) (table 3). VAT 9 was correlated to
plasma glucose levels, VAT 40 was correlated to both
plasma insulin levels and BMI, and VAT 31 was corre-
lated to gender.
Correlations between the modules, associated to a
trait, and all the traits were recalculated taking into
account various potential confounding factors. Such
confounding factors might be women’s menopausal sta-
tus, the use of hormone therapy, and treatment for dia-
betes, hypertension, or dyslipidemia (Additional file 11,
T a b l eS 8 ) .A g e ,g e n d e r ,m e n o p a u s a ls t a t u s ,h o r m o n e
treatment, and treatment for diabetes, hypertension, and
dyslipidemia did not influence the results of the uncor-
rected correlation analysis (Additional file 12, Table S9A
a n dS 9 B ) .C o r r e c t i o nf o rB M Is h o w e dt h a tB M Ii sa
confounder for the correlations between plasma insulin
levels and module VAT 40, which is in line with the sig-
nificant correlation between module VAT 40 and both
BMI and plasma insulin levels. BMI also confounds the
correlation between module SAT 8 and plasma HDL
levels. However, since insulin and BMI are not corre-
lated to this module if corrected for plasma HDL levels
(p-values of 0.276 and 0.331 respectively) we conclude
that plasma HDL levels, and not BMI or plasma insulin
levels, drive module SAT 8.
Figures 4 and 5 show gene co-expression networks
that consist of all the genes that reside in modules asso-
ciated to a metabolic trait and that are individually
strongly correlated - r > 0.65 - to another gene within
the module. Some genes that belong to the module are
thus not included in these figures because they are not
strongly correlated to an individual gene, but instead
they are strongly correlated to the average of a set of
genes that make up the module. However most of the
Table 2 Overlap between genes in the 10 largest modules identified in subcutaneous (SAT) and visceral adipose tissue
(VAT)
SAT 1 SAT 2 SAT 3 SAT 4 SAT 5 SAT 6 SAT 7 SAT 8 SAT 9 SAT 10
Total 723 554 344 308 146 75 87 87 103 46
VAT 1 469 20 1 27 2 *
5 69 *
6 29 0 0 0 0
VAT 2 641 *
1 5 3 63 1 2117008 1
VAT 3 524 9*
2 3 0 7170000 3 1 0
VAT 4 464 522 1 651 *
7 27 3 0 0
VAT 5 306 16 3 0 *
4 5 600044 0
VAT 6 253 60 *
3 1 1 5110000 0
VAT 7 193 50 3 2060000 1
VAT 8 209 2 7 2 3100000 *
9 58 0
VAT 9 103 000 3 2001 *
8 54 0 0
VAT 10 104 0 6 00100005 0
After generation of modules in both types of adipose tissue, the overlap in gene content of the 10 largest modules in VAT and SAT was determined. As an
example, modules VAT 2 and SAT 1 are largely the same since approximately 75% of the genes present in one of these modules is also present in the other. For
most, although not all, of the modules in one adipose tissue there is a similar module in the other adipose tissue. P-values to determine the significance of the
overlap between the modules were performed using a Fisher’s exact test: *1: p = 1.54 × 10
-321; *2: p = 1.20 × 10
-321; *3: p = 2.07 × 10
-138; *4: p = 1.58 × 10
-43; *5:
p = 5.74 × 10
-73; *6: p = 6.65 × 10
-28; *7: p = 3.33 × 10
-23; *8: p = 2.16 × 10
-107; *9: p = 1.33 × 10
-89. Genes within module SAT 10 overlap with genes within
module VAT 11 (not shown).
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lated expression levels to other individual genes within
the same module, which validates our approach. More-
over most of the genes within a module are individually
correlated - although not significant after stringent cor-
rection - to the trait that is correlated with the whole
module, which is depicted by different colours in figures
4 and 5.
These data suggest that genes co-expressed in SAT
mainly modulate plasma HDL levels, while genes co-
expressed in VAT may affect plasma glucose and insulin
levels, thereby contributing to the development of type
2 diabetes.
Genes co-expressed in adipose tissue involved in immune
and metabolic processes
To further define the biological mechanisms represented
by the genes in the modules correlated to the metabolic
traits, we used the Panther gene classification tool (table
4). Module SAT 4, consisting of 308 genes, harboured
significantly more genes than would be expected by
chance that are involved in immunity and defense,
humoral immunity (B-cell, T-cell), cell adhesion, trans-
port, signal transduction, ion transport (cation trans-
port), intracellular signalling, carbohydrate metabolism,
and “lipid, fatty acid, and steroid metabolism”.S A T8
contained 87 genes and was markedly enriched in genes
involved in immunity and defense, humoral immunity
(B-cells, T-cells, MHCII), innate immunity (comple-
ment-mediated, macrophages), and endocytosis. VAT 9
harboured 103 genes and correlated with plasma glucose
levels. It contained many genes involved in immunity
and defense, macrophage-mediated immunity, cell adhe-
sion, and transport. The genes in this module resemble
the genes found in SAT modules 4 and 8; 32 genes are
present in both SAT 4 and VAT 9, and 54 genes are
present in SAT 8 and VAT 9. The other modules corre-
lated to a metabolic trait (SAT 13, SAT 39, VAT 40)
but could not be used for reliable pathway analyses
since the number of genes residing in these modules is
too small.
To further explore the functional relationships
between genes in SAT modules 4 and 8 we used KEGG
pathway analysis, and PubMed and OMIM gene descrip-
tions. We did not focus on module VAT 9 because this
module contains the same but less genes as modules
SAT 4 and SAT 8 and is therefore less preferable for
pathway analyses. Figure 6 shows an overview of genes
that are present in SAT modules 4 and 8, and that,
based on current knowledge, could be assigned a certain
biological function. Interestingly, SAT 4 genes (classified
by Panther analysis to be involved in “carbohydrate
metabolism”,a n d“lipid, fatty acid, and steroid metabo-
lism”) encode proteins involved in the structure or mod-
ification of the HDL particle, lysosomal degradation, and
cholesterol metabolism and trafficking in macrophages.
Figure 2 Correlations between modules in subcutaneous adipose tissue and metabolic traits. -Log p-values for Spearman rank correlation
coefficients between the values of the modules and the different metabolic traits are shown for subcutaneous adipose tissue. Modules are
ordered on the X-axis in the same way as in Additional file 7, Table S6A and S6B; thus with the largest module - containing the largest number
of probes - on the left. The dashed line represents a highly stringent Bonferroni corrected p-value of 0.05.
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Page 7 of 15Furthermore, the presence of certain metabolic genes
points towards a decrease of glycolysis, increased gen-
eration of pyruvate, acetate, and acetaldehyde from
other sources than glycolysis, and upregulation of amino
acid metabolism and glycerophospholipid metabolism.
Among those genes residing in both SAT 4 and SAT
8 involved in immune-related processes, several are
members of well-described pathways. As an example,
several members of Fcg receptor-mediated signalling are
present in SAT 4 and 8, including FCGR2A, FCGR2B,
Gardner-Rasheed feline sarcoma viral (v-fgr) oncogene
homolog (FGR) [23,24], spleen tyrosine kinase (SYK)
[25,26], protein tyrosine phosphatase 6, non-receptor
type 6 (PTPN6; also called SHP-1), TYRO protein tyro-
sine kinase binding protein (TYROBP;a l s oc a l l e d
DAP12), and cytochrome b-245, alpha polypeptide
(CYBA) [27,28]. Another example of a pathway that is
overrepresented amongst the genes present in modules
SAT 4 and SAT 8 is the Toll-like receptor signalling
pathway. Genes that belong to this pathway are Toll-like
receptor 5, 7, and 8 (TLR5, TLR7, TLR8), CD14 mole-
cule (CD14), lymphocyte antigen 96 (LY96;a l s ok n o w n
Table 3 Modules correlated with metabolic traits in subcutaneous (SAT) and visceral adipose tissue (VAT)
Tissue Module ID Correlated trait No. of genes in module Correlation
coefficient
P-value
SAT 31 Gender 14 6.6 × 10
-66
4 HDL cholesterol 308 -0.58 2.5 × 10
-7
13 Glucose 28 -0.51 7.0 × 10
-6
Triglycerides -0.50 1.8 × 10
-5
8 HDL cholesterol 87 -0.49 2.7 × 10
-5
39 HDL cholesterol 7 -0.49 3.0 × 10
-5
VAT 31 Gender 14 8.2 × 10
-60
40 Insulin 12 -0.54 4.3 × 10
-6
BMI -0.49 2.8 × 10
-5
9 Glucose 103 0.50 2.1 × 10
-5
Only those modules significantly correlated to a metabolic trait after Bonferroni correction are shown, with the names of the modules, the traits to which they
were correlated, the number of genes that comprise the module, and the Spearman rank correlation coefficient between the value of the module - i.e. the
average of all the probes in the module - and the trait. To calculate p-values for association between a module and gender we used a students T-test.
Figure 3 Correlations between modules in visceral adipose tissue and metabolic traits. -Log p-values for Spearman rank correlation
coefficients between the values of the modules and the different metabolic traits are shown for visceral adipose tissue. Modules are ordered on
the X-axis in the same way as in Additional file 7, Tables S6A and S6B; thus with the largest module - containing the largest number of probes -
on the left. The dashed line represents a highly stringent Bonferroni corrected p-value of 0.05.
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Page 8 of 15as MD-2), Bruton agammaglobulinemia tyrosine kinase
(BTK) [29], and myeloid differentiation primary
response gene (88) (Myd88). Our data thus suggest that
some genes in SAT 4 and SAT 8 are involved in
immune-related signalling pathways such as the Toll-
like receptor signalling and the Fcg receptor-mediated
signalling pathways.
Discussion
In this study, we have identified genes expressed in SAT
and VAT that are related to lipid and glucose metabo-
lism parameters in obesity. In particular, plasma levels
of HDL cholesterol and glucose were found to be corre-
lated to sets of co-expressed, and thus functionally
related, genes (modules). Remarkably, several SAT mod-
ules were correlated to plasma HDL cholesterol levels
and one VAT module was correlated to plasma glucose
levels, although these SAT modules contained primarily
the same genes as the VAT module. This difference
highlights the fact that SAT and VAT have a distinct
biological role. In silico classification of the co-expressed
genes revealed that a significant number are involved in
immunity and metabolism. This is in line with the con-
cept that the immune and metabolic systems are tightly
interconnected and that this interconnection is pivotal
in the development of co-morbidities of obesity.
Several of the genes we have identified in this study
play a role in pathways or processes that have already
been linked to obesity co-morbidity, in particular HDL
levels. These pathways or processes include immunity-
related signalling pathways, the complement cascade,
cholesterol metabolism and trafficking, lysosomal
Figure 4 Gene co-expression network of modules in subcutaneous adipose tissue correlated to a trait. Genes in a module that have an
individual Pearson correlation coefficient >0.65 are connected. Genes that are individually correlated (p < 0.01) to the metabolic trait to which
the whole module is correlated are shown in red (HDL), purple (glucose), yellow (triglycerides), or green (both glucose and triglycerides). The
CD86 and TNFSF13B genes are present in both modules SAT 4 and SAT 8 because different probes targeting this gene are highly correlated to
different modules.
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Page 9 of 15degradation and trafficking, and composition of the
HDL particle [30-40]. A crucial finding of this study is
the identification of novel genes that are correlated to
HDL and glucose levels in severely obese individuals.
The role of these genes in obesity co-morbidity is largely
unknown, and further research is required to unravel
the relationship between these genes and HDL and glu-
cose levels. Possibly these genes may control plasma
HDL cholesterol and glucose levels, or they might be
involved in the response of adipose tissue to changed
plasma HDL and glucose levels.
An earlier micro array study performed by Tchkonia
et al [41] investigated differences in gene expression
levels between differentiated and undifferentiated adipo-
cytes derived from subcutaneous, visceral, and mesen-
teric adipose tissue. We observed an overlap between
the results of this study and our own data that was
higher than expected: In our study we identified 1344
genes to be upregulated in SAT and 1246 in VAT. Of
these 1344 and 1246 genes, 103 and 87 respectively had
also been identified in the study of Tchkonia et al,
which identified 920 transcripts to be differently
expressed across fat depots in either differentiated or
undifferentiated cells (overrepresentation p-values: 2.5 ×
10
-7 for SAT and 8.7 × 10
-5 for VAT, Fisher’se x a c tt e s t
assuming that 20,000 unique genes were tested in total).
Of the 87 genes differentially expressed in the study of
Tchkonia et al that overlapped with genes upregulated
in VAT in our study, 76 (87%) were differentially
expressed in undifferentiated adipocytes that had been
derived from distinct fat depots. 39 of these 76 genes
(51%) were present in module VAT 4, which is substan-
tially higher than expected (p-value: 2.5 × 10
-11;F i s h e r ’s
exact test, again assuming that 20,000 different genes
were tested). These observations make it tempting to
speculate that this module is related to processes in
VAT-specific undifferentiated adipocytes. This is line
with absence of a module in SAT that contains the
same genes as module VAT 4.
Previous studies on the effects of obesity on genome-
wide expression levels in SAT revealed several classes
of genes to be regulated by obesity [12,13]. Downregu-
lated genes in obesity include lipolytic genes. Upregu-
lated genes include genes controlling the structure and
Figure 5 Gene co-expression network of modules in visceral adipose tissue correlated to a trait.G e n e si nam o d u l et h a th a v ea n
individual Pearson correlation coefficient >0.65 are connected. Genes that do not have an individual correlation of >0.65 with any other gene in
the module are not shown. Genes that are individually correlated (p < 0.01) to the metabolic trait to which the whole module is correlated are
shown in purple (glucose), green (insulin), or yellow (BMI and insulin).
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Page 10 of 15turnover of the extracellular matrix (ECM) and genes of
infiltrating immune cells encoding cytokines and plasma
membrane proteins. Another study investigating gene
expression levels in whole SAT before and after weight
loss [11] found similar sets of genes as found in the stu-
dies mentioned above [12,13]. A subset of these genes
was shown to be linked to glucose disposal rate, indicat-
ing that they may be involved in insulin resistance.
Among the genes involved in immunity and the ECM,
there was an overrepresentation of genes expressed in
immune cells (e.g. macrophages), whereas genes
involved in lipid metabolism were mostly genes
expressed in adipocytes. Investigation of 31 genes speci-
fically expressed in macrophages but not in adipocytes
[11] revealed that these genes show significantly differ-
ent gene expression profiles during weight loss induced
by a stringent diet. 2 genes did not respond to this diet,
whereas 7 genes responded strongly, 11 genes responded
weakly, and another 11 genes showed an intermediate
response [11].
In our studies of a group of 75 severely obese indivi-
duals, the genes in SAT modules 4 and 8, and VAT
module 9 showed significant overlap with the genes dif-
ferentially expressed after weight loss [11], as well as
with the genes differentially expressed between lean and
obese individuals [12] (Additional file 13, Table S10A).
In addition, genes in these modules overlap with macro-
phage genes differentially expressed during dietary inter-
vention and with genes predictive of insulin sensitivity
(Additional file 13, Table S10B and S10C). Strikingly, of
the 31 genes specifically expressed in macrophages but
not in adipocytes investigated by Capel et al. [11], 26
are present in SAT modules 4 and 8, which are corre-
lated to HDL levels (p = 2.1 × 10
-40;F i s h e r ’s exact test
Table 4 Over-represented Panther biological processes in modules correlated to a metabolic trait in subcutaneous
(SAT) and visceral adipose tissue (VAT)
SAT Module 4 SAT Module 8 VAT Module 9
No. of genes in
module
P-value No. of genes in
module
P-value No. of genes in
module
P-value
Total 308 87 103
Signal transduction 67 2.8 × 10
-
4
NA NS NA NS
- Intracellular signalling cascade 26 2.0 × 10
-
3
NA NS NA NS
Immunity and defense 43 3.5 × 10
-
9
31 4.1 × 10
-
17
21 8.2 × 10
-
7
- T-cell-mediated immunity 13 9.2 × 10
-
5
7 6.4 × 10
-4 NA NS
- MHCII-mediated immunity NA NS 5 2.5 × 10
-5 NA NS
- Macrophage-mediated immunity NA NS 7 7.5 × 10
-5 5 3.3 × 10
-
2
- Endocytosis NA NS 7 6.2 × 10
-3 NA NS
- B-cell and antibody-mediated
immunity
7 2.4 × 10
-
2
4 4.9 × 10
-2 NA NS
- Complement mediated immunity NA NS 4 2.4 × 10
-3 NA NS
Transport 41 2.8 × 10
-
7
NA NS 16 1.2 × 10
-
3
- Ion transport 23 1.8 × 10
-
4
NA NS NA NS
Cell adhesion 20 1.6 × 10
-
3
NA NS 11 9.2 × 10
-
4
Lipid, fatty acid and steroid
metabolism
21 9.7 × 10
-
3
NA NS NA NS
Carbohydrate metabolism 19 2.5 × 10
-
3
NA NS NA NS
Other 89 NA 37 NA 44 NA
Unclassified 76 NA 19 NA 24 NA
SAT modules 4 and 8 correlate to HDL, and VAT module 9 correlates to glucose. The modules SAT 12, SAT 39, VAT 40 do not contain enough genes to perform a
reliable pathway analysis. The modules correlated to gender in both tissues consist solely of Y-chromosomal genes and are not included in the table.
Only biological functions that are over-represented in a module after Bonferroni correction are shown. For each over-represented biological function the number
of genes in the module that belong to this biological function, and the corresponding Bonferroni corrected p-value for over-representation are shown. The
number of genes that are part of a class which is not over- or under-represented, and the number of genes that could not be classified by PANTHER are also
shown for each module ("other” and “unclassified” respectively). NA, not applicable; NS, not significant.
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Page 11 of 15assuming that 20,000 different genes were tested). More-
over the grouping of these macrophage genes based on
different expression patterns during dietary intervention
closely resembles the grouping of the genes in SAT
modules 4 and 8 generated in our study; 6 of 7 genes
identified as high responders to energy restriction
regarding their expression are present in module SAT 4,
and 10 of 11 genes identified as low responders are pre-
sent in module SAT 8 [11]. The overlap of genes found
in these studies with different designs - comparing lean
with obese individuals, studying the same individuals
after weight loss, and studying quantitative metabolic
traits in obese individuals - supports these approaches
and strongly suggests that the genes identified are
involved in obesity-related disease mechanisms.
It should be noted that the correlations between the
modules and the metabolic traits identified in our study
are not driven by BMI, since BMI itself was not corre-
lated to the modules - except VAT 40. The correlation
between module SAT 8 and plasma HDL levels was
confounded by BMI and plasma insulin levels, but the
absence of any correlation between this module and
BMI or plasma insulin levels after correction for plasma
HDL levels, indicates that HDL is the driver of this
module. It can be speculated that module SAT 8 repre-
sents a BMI/plasma insulin driven effect of HDL
whereas module SAT 4 represents an effect of HDL
independent of BMI/plasma insulin.
A remaining question is what biological phenomena
are driving the modules correlated to a metabolic trait.
Here, we will mainly focus on SAT modules 4 and 8,
because these two modules contain the largest number
of genes, making it more valid to identify over-repre-
sented pathways in them. Capel et al. [11] investigated
31 genes specifically expressed in macrophages but not
in adipocytes. Of these, 26 are present in SAT modules
4 and 8, which are correlated to HDL levels. The pre-
sence of genes within these modules that are specifi-
cally expressed in macrophages, might be a reflection
of the relative number of macrophages in the whole
adipose tissue and it is possible that SAT modules 4
and 8 are, at least in part, driven by the degree of
macrophage infiltration. The presence of two different
modules of macrophage genes, as confirmed by
Figure 6 Overview of pathways in subcutaneous adipose tissue related to plasma HDL-cholesterol levels. KEGG pathways, and PubMed
and OMIM gene descriptions were used to generate an overview of the functions of the genes in SAT modules 4 and 8. Of the 395 genes
present in both modules, approximately 200 genes could be assigned a function related to other genes in the two modules. These
approximately 200 genes were included in the figure in order to present a schematic overview of processes involved in SAT modules 4 and 8.
There is evidence that modules SAT 4 and SAT 8 represent different biological processes, but it is unclear what these differences exactly are.
Genes in yellow belong to module SAT 4 and genes in green belong to SAT 8. Cellular trafficking of cholesterol is indicated with arrows. CE,
cholesteryl esters.
Wolfs et al. BMC Medical Genomics 2010, 3:34
http://www.biomedcentral.com/1755-8794/3/34
Page 12 of 15grouping of the macrophage genes by Capel et al.,
m i g h tb ed r i v e nb yd i f f e r e n c e sb e t w e e no rw i t h i n
macrophages (e.g. macrophage infiltration or activa-
tion). Another possible biological mechanism that
might underlie the appearance of SAT modules 4 and
8 are differences in adipocyte size, since with equal
numbers of macrophages per m
3 the relative amount
of macrophage mRNA would increase if adipocytes get
larger. Other mechanisms that may operate are the
induction of adipocyte autophagy, ER-stress, or inflam-
masome activation. In order to get insight into these
questions histology experiments are required to quan-
titate macrophage infiltration, adipocyte size, markers
of autophagy, ER-stress, and inflammasome activation.
Of note, 13 of the 31 macrophage-specific genes were
also present in VAT module 9. This overlap is still
highly significant, although less striking than in SAT
(p = 1.6 × 10
-22;F i s h e r ’s exact test assuming that
20,000 different genes were tested).
Importantly, VAT is the most metabolically active fat
depot, and it has been proposed that complications of
obesity correlate to an excess of visceral fat rather than
to subcutaneous fat accumulation [9,10]. However,
many studies investigating gene expression in adipose
t i s s u eh a v eo n l yf o c u s e do nS A T .I no u rs t u d y ,w e
included samples from both fat depots and we identified
numerous genes differentially expressed in VAT and
SAT. In this regard our results are in line with a pre-
vious study in ten nondiabetic, normolipidemic obese
m e n[ 4 2 ] ,b u td u et oo u rl a r g e rs a m p l es i z ew ew e r e
able to detect more genes differentially expressed in
SAT and VAT.
Unexpectedly the module correlated to plasma glucose
levels in VAT contained primarily the same genes as the
modules correlated to plasma HDL cholesterol levels in
SAT. Moreover the genes differentially expressed in
SAT and VAT were not correlated to any of the para-
meters we tested, and expression levels of the genes that
were correlated to plasma HDL levels in SAT and glu-
cose levels in VAT were similar in both tissue types.
This could indicate that although gene expression levels
in VAT and SAT are associated with different plasma
parameters - glucose and HDL levels, respectively - the
molecular perturbations that underlie these associations
are the same. Further, it might imply that gene expres-
sion in SAT is a reasonably good “model” for gene
expression in VAT in regard to HDL and glucose
metabolism.
Conclusions
In conclusion, our data confirm the genes and pathways
that were associated to obesity in earlier studies; they
are mainly related to immunity and metabolism and
include immunity-related signalling pathways, the
complement cascade, cholesterol metabolism and traf-
ficking, lysosomal degradation and trafficking, and com-
position of the HDL particle. Our study also reveals
large sets of novel genes differentially expressed across
VAT and SAT and genes involved in HDL cholesterol
and glucose metabolism parameters in obesity. Finally,
we have shown that genes with expression levels corre-
lated to plasma HDL cholesterol and glucose levels are
the same in SAT and VAT, but whereas such genes cor-
relate to plasma HDL levels in SAT, they correlate to
plasma glucose levels in VAT.
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Additional file 1: Table S1. Genes picked by random stratified
selection and primer sequences used for qRT-PCR. Overview and
primer sequences of the genes selected through random stratified
selection for the qRT-PCR validation experiment.
Additional file 2: Table S2. Correlations between age, BMI, and
plasma parameters of the study population. Overview of significant
correlations between traits measured in the study population. Both
Pearson correlation coefficients (left side of table) and p-values (right side
of table) are shown for those correlations that have a p-value <0.01.
Correlations significant after Bonferroni correction are marked with an
asterisk. Data (except for age and BMI) have been transformed to a
natural logarithm to obtain a normal distribution. TG, triglycerides; NEFA,
non-esterified fatty acid; ALAT, alanine aminotransaminase; ASAT,
aspartate aminotransaminase; CRP, C-reactive protein.
Additional file 3: Table S3. Overview of microarray and qRT-PCR
results. Comparison of qRT-PCR and microarray data from 20 randomly
stratified selected genes in order to validate the quality of the microarray
data.
Additional file 4: Figure S1. Correlation plot of microarray and qRT-
PCR results. Correlation plot of the fold changes in the microarray and
the qRT-PCR experiments for 20 randomly stratified selected genes. The
y-axis shows the Log2 averaged fold changes for the 20 genes tested as
calculated in the qRT-PCR experiment. The x-axis shows Log2 averaged
fold changes for these genes as detected in the microarray experiment.
The fold changes obtained in the qRT-PCR and microarray experiments
are strongly correlated (r = 0.88).
Additional file 5: Table S4A and S4B. Genes significantly
upregulated in (A) subcutaneous and (B) visceral adipose tissue. List
of genes significantly upregulated in subcutaneous and visceral adipose
tissue.
Additional file 6: Table S5A and S5B. Gene Set Enrichment Analysis
of genes differentially expressed in (A) subcutaneous adipose tissue
and (B) visceral adipose tissue. Overview of biological processes
overrepresented among genes differentially expressed in subcutaneous
and visceral adipose tissue.
Additional file 7: Table S6A and S6B. Contents of the modules
generated in (A) subcutaneous and (B) visceral adipose tissue.F o r
each module, the number of probes in the module, the number of
genes corresponding to these probes, and the names of all those genes
are listed.
Additional file 8: Figure S2. Coloured heatmap of modules in
subcutaneous adipose tissue. Pair-wise correlations between probes
residing in all the modules identified in SAT were plotted. Probe pairs
strongly positively correlated are shown in green and probe pairs
strongly negatively correlated are shown in red. Colour intensity
represents the strength of the correlation. The modules are indicated by
white squares and are ordered in the same way as in Additional file 7,
Tables S6A and S6B; thus with the largest module - containing the
largest number of probes - in the upper left corner and the smallest
module in the lower right corner.
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Page 13 of 15Additional file 9: Figure S3. Coloured heatmap of modules in
visceral adipose tissue. Pair-wise correlations between probes residing
in all the modules identified in VAT were plotted. Probe pairs strongly
positively correlated are shown in green and probe pairs strongly
negatively correlated are shown in red. Colour intensity represents the
strength of the correlation. The modules are indicated by white squares
and are ordered in the same way as in Additional file 7, Tables S6A and
S6B; thus with the largest module - containing the largest number of
probes - in the upper left corner and the smallest module in the lower
right corner.
Additional file 10: Table S7A and S7B. Gene Set Enrichment
Analysis of genes in the modules in (A) subcutaneous adipose
tissue and (B) visceral adipose tissue. Overview of biological processes
overrepresented among modules identified in subcutaneous and visceral
adipose tissue.
Additional file 11: Table S8. Relevant medication and menopausal
status of the severely obese individuals. Overview of prescribed
medication relevant for tested traits, and menopausal status of the
severely obese individuals. Patient ID’s correspond with the patient ID’s
deposited in the Gene Expression Omnibus database. Patients that
received no relevant medication are not included in the table.
Dyslipidemia treatment consists of statins, and treatment of hypertension
consists of ACE-inhibitors, Angiotensin Receptor Blockers, and Calcium
antagonists.
Additional file 12: Table S9A and S9B. Correlations between
modules in (A) subcutaneous adipose tissue and (B) visceral
adipose tissue, and traits after correction for possible confounding
factors. Overview of correlations between modules and traits after
correction for confounding factors - menopausal status, hormone
treatment and treatment for diabetes, hypertension, dyslipidemia, along
with all the other traits we measured: gender, age, BMI, plasma levels of
glucose, insulin, HbA1c, triglycerides, non-esterified fatty acids, HDL
cholesterol, LDL cholesterol, total cholesterol, CRP, ALAT, and ASAT - in
(A) subcutaneous and (B) visceral adipose tissue. The last two columns in
the table show Spearman rank correlation coefficients and p-values for
the correlation between the module and the associated trait - as shown
in columns 2 and 3 - corrected for potential confounders, which are
listed in the first column. TG, triglycerides; NEFA, non-esterified fatty acid;
ALAT, alanine aminotransaminase; ASAT, aspartate aminotransaminase;
CRP, C-reactive protein.
Additional file 13: Table S10A, S10B, and S10C. Overlap in genes
identified in our study and the study of Capel et al. in
subcutaneous adipose tissue. Overview of the overlap between the
results of the present study and an earlier microarray study in
subcutaneous adipose tissue of severely obese subjects performed by
Capel et al. [11].
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